Calliditas Therapeutics AB (publ)
SSE:CALTX.ST
Overview | Financials
Company Name | Calliditas Therapeutics AB (publ) |
Symbol | CALTX.ST |
Currency | SEK |
Price | 107.8 |
Market Cap | 5,785,850,440 |
Dividend Yield | 0% |
52-week-range | 80.8 - 141.9 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Ms. Renee Aguiar-Lucander |
Website | https://www.calliditas.se |
An error occurred while fetching data.
About Calliditas Therapeutics AB (publ)
Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment of the autoimmune renal disease immunoglobulin
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD